- Click here for ScotusBlog.
Issues:
(1) Whether respondents have Article III standing to challenge the Food and Drug Administration’s 2016 and 2021 actions with respect to mifepristone’s approved conditions of use;
(2) whether the FDA’s 2016 and 2021 actions were arbitrary and capricious; and
(3) whether the district court properly granted preliminary relief.
- Oyez.
- Wikipedia.
- What is the FDA?
- What is the Alliance for Hippocratic Medicine?